Shares of Pediapharm Inc. (CVE:PDP – Get Free Report) were up 1.7% on Friday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The firm has a market capitalization of C$66.36 million and a P/E ratio of -4.11. The stock has a fifty day moving average of C$0.30 and a 200-day moving average of C$0.30. The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Recommended Stories
- Five stocks we like better than Pediapharm
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Meta Takes A Bow With Q1 Earnings – Watch For Tariff Impact in Q2
- Market Cap Calculator: How to Calculate Market Cap
- Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious
- ETF Screener: Uses and Step-by-Step Guide
- Palantir Earnings: 1 Bullish Signal and 1 Area of Concern
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
